A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT<sup>®</sup>) Randomized Controlled Trial

2008343 citationsJournal Article

Authors

Stefanie Kulnigg · Medical University of Vienna

S Stoĭnov · National Institute of Emergency Medicine "Pirogov"

Vladimir Simanenkov · City Hospital No. 40

Larisa Dudar · Crimean Agrotechnological University

Waldemar Karnafel · Hospital Central Dr. Ignacio Morones Prieto

Luis Chaires Garcia · Hospital Central Dr. Ignacio Morones Prieto

Alicia M. Sambuelli

Abstract

FeCarb is effective and safe in IBD-associated anemia. It is noninferior to FeSulf in terms of Hb change over 12 wk, and provides a fast Hb increase and a sufficient refill of iron stores.

Topics & Keywords

Iron Metabolism and Disorders Hemoglobinopathies and Related Disorders Trace Elements in Health

Publication Details

Published in: The American Journal of Gastroenterology

Volume 103, Issue 5, pp. 1182-1192

DOI: 10.1111/j.1572-0241.2007.01744.x

Field-Weighted Citation Impact: 10.19

Command Palette

A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT<sup>®</sup>) Randomized Controlled Trial

Authors

Abstract

Topics & Keywords

Publication Details